Researchers have long struggled to study sudden cardiac arrests that take place outside of hospitals. An ongoing EU-funded project is harmonising research from across Europe to bring clarity to this complex disease.
EU and industry funded researchers are shedding light on genes that influence the progression of Alzheimer's disease, paving the way for the development of novel drugs and therapeutic strategies that could delay or slow cognitive decline.
EU and industry-funded researchers are testing wearable devices, Internet of Things technologies and smartphone apps to transform the lives of people with Alzheimer's disease. The innovative approach promises to enable people with declining cognitive health to live independently for longer, while lowering costs for public health services.
Treatment options for the immune system disorder Graves' disease have remained unchanged for over 70 years, and all bring serious side effects. An innovative EU-funded project is helping scientists and doctors move closer to finding a safer, more effective alternative.
An EU-funded project investigated how pathogenic viruses, including influenza A, take control of the protein synthesis machinery in human cells. This has provided valuable new knowledge, which paves the way for new flu treatments.
The EU-funded WATERSPOUTT project's partners in Malawi are designing and testing an innovative solar-ceramic water filtration system capable of providing local communities with a reliable source of clean water at the household level.
An EU-funded project has made a breakthrough in medical imaging. By developing a photon-counting detector for CT scanners, higher-resolution images with lower radiation doses can be produced for accurate non-invasive screening and diagnosis of diseases.
Spices have been used in food and traditional medicine for millennia. But a new interpretation of 'SPICES' is coming to mitigate cardiovascular risk factors in carefully selected sites in parts of sub-Saharan Africa and Europe... the international research kind.
In the field of pharmaceuticals, the term 'polymorphism' refers to the existence of a single substance in two or more crystalline forms. These different forms can vary widely in their efficacy, bioavailability and even toxicity. An EU-funded project is working to develop a method for directing polymorphism in pharmaceutical compounds, thus promising better drug treatments for patients everywhere.
EU-funded researchers have discovered an important new mechanism by which cells flag and repair damage to their DNA - an unexpected finding that could improve the treatment of diseases such as cancer.